1
                      SECURITIES AND EXCHANGE COMMISSION
                           Washington, D.C.  20549

- - -------------------------------------------------------------------------------


                                SCHEDULE 13D/A

                  Under the Securities Exchange Act of 1934
                              (Amendment No. 1)

                               IVAX CORPORATION
                               (Name of Issuer)

                    Common Stock, Par Value $.10 per Share
                        (Title of Class of Securities)

                                   46582310
                                (CUSIP Number)

                            Milan A. Sawdei, Esq.
                         Bergen Brunswig Corporation
                           4000 Metropolitan Drive
                          Orange, California   92868
                          Telephone:  (714) 385-4000
                    (Name, Address and Telephone Number of
                   Person Authorized to Receive Notices and
                               Communications)

                                   Copy to:

                         John A. Marzulli, Jr., Esq.
                             Shearman & Sterling
                             599 Lexington Avenue
                          New York, New York  10022
                          Telephone:  (212) 848-4000

                                March 20, 1996
           (Date of Event which Requires Filing of this Statement)
- - --------------------------------------------------------------------------------

If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box _.



   2
CUSIP No. 4652310

(1)   Name of Reporting Person
      S.S. or I.R.S. Identification No. of Above Person
            BERGEN BRUNSWIG CORPORATION
            I.R.S. IDENTIFICATION NO. 22-1444512

(2)    Check the Appropriate Box if a Member of Group (See Instructions)

_  (a)

_  (b)

(3)    SEC Use Only


(4)    Sources of Funds (See Instructions) NOT APPLICABLE.


(5)    Check if Disclosure of Legal Proceedings is Required Pursuant to
      Items 2(d) or 2(e).


(6)   Citizenship or Place of Organization  NEW JERSEY

Number of         (7)   Sole Voting Power
Shares
Beneficially      (8)   Shared Voting Power 15,134,384
Owned by
Each              (9)   Sole Dispositive Power 30,177,342
Reporting
Person            (10)  Shared Dispositive Power
WITH

(11)  Aggregate Amount Beneficially Owned by Each Reporting Person 45,311,726

(12)  Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See
      Instructions)



(13)  Percent of Class Represented by Amount in Row (11)
               29.9%

(14)  Type of Reporting Person (See Instructions)     CO



   3
      Bergen  Brunswig  Corporation,  a  New Jersey corporation (the "Reporting
Person") hereby amends and supplements its  Schedule 13D relating to the shares
of  common  stock, par value $.10 per share, of  IVAX  Corporation,  a  Florida
corporation (the "Issuer").

Item 4.     PURPOSE OF TRANSACTION.

      The Reporting  Person  has  terminated  the Agreement and Plan of Merger,
dated  as of November 10, 1996 (the "Merger Ageement"),  among  BBI  Healthcare
Corporation,  a  Delaware  corporation, the Issuer, the Reporting Person, BBI-I
Sub,  Inc.,  a  Florida  corporation,   and  BBI-B  Sub,  Inc.,  a  New  Jersey
corporation.

      In connection with the termination  of  the Merger Agreement, the
Reporting Person intends  to file a lawsuit against the Issuer in  the  United
States  District Court for  the  Southern  District  of  New  York alleging,
among other things, various breaches of the Merger Agreement.


   4
                                      2
SIGNATURE

      After reasonable inquiry and to the best  of  my  knowledge and belief, I
certify that the information set forth in this Statement  is true, complete and
correct.

March 20, 1997                            BERGEN BRUNSWIG CORPORATION

                                          By /S/      MILAN A. SAWDEI
                                               Name:  Milan A. Sawdei
                                               Title: Executive Vice President,
                                                      Chief Legal Officer and
                                                      Secretary